Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-12-18 10:35:06
Reference is made to Circio Holding ASA's (the "Company") stock exchange
announcement on 9 March 2023, in which the Company announced that it had
requested Atlas Special Opportunities, LLC ("Atlas") to subscribe and pay for
the first tranche of convertible bonds under the Investment Agreement entered
into between Atlas and the Company, consisting of 75 convertible bonds.
Atlas has, by a notice of conversion issued to Nordic Trustee AS, requested
conversion of convertible bonds with a nominal value of NOK 500,000 which,
pursuant to the bond terms, are convertible into 77,097 new shares in the
Company at a conversion price of NOK 6.4853.
The Company's share capital will accordingly be increased by NOK 46,258.20 by
the issuance of 77,097 new shares upon completion of the conversion by
registration of the share capital increase in the Norwegian Register of Business
Enterprises (Nw.: Foretaksregisteret). Following the conversion, the Company's
total share capital will be NOK 4,438,028.40, divided into 7,396,714 shares,
each with a nominal value of NOK 0.60.
For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: erik.wiklund@circio.com (erik.wiklund@targovax.com)
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@circio.com (renate.birkeli@targovax.com)